Director/PDMR Shareholding
CVS Group plc announced that its Chief Financial Officer, Robin Alfonso, purchased 768 ordinary shares on August 6, 2026, at a price of 1,294.2662 pence per share. This transaction increases his total interest in the company, including associated persons, to 26,015 ordinary shares, representing 0.038% of the total voting rights. This notification is made in accordance with UK Market Abuse Regulation.
Select text to share a quote on X · sign in to keep highlights & notes in your CVSG notes
CVS, the UK's listed veterinary group and a leading provider of veterinary services, announces that it was notified on 6 August 2026 that Robin Alfonso, Chief Financial Officer of the Company, purchased a total of 768 ordinary shares of 0.2p each in the Company ("Ordinary Shares") on the same date.
As a result, Robin Alfonso's total interest in the Company, including all persons closely associated, is now at 26,015 Ordinary Shares, representing 0.038% per cent of the total voting rights of the Company.
| 1 | Details of the person discharging managerial responsibilities / person closely associated | |||||
| a) | Name | Robin Alfonso | ||||
| 2 | Reason for the notification | |||||
| a) | Position/status | PDMR (Chief Financial Officer) | ||||
| b) | Initial notification /Amendment | Initial Notification | ||||
| a) | Name | CVS Group plc | ||||
| b) | LEI | 213800J41XDQ2NX48O05 | ||||
| a) | Description of the financial instrument, type of instrument Identification code | Ordinary shares of 0.2 pence each GB00B2863827 | ||||
| b) | Nature of the transaction | On-market purchase | ||||
| c) | Price(s) and volume(s) |
| ||||
| d) | Aggregated information - Aggregated volume - Price | N/A - single transaction | ||||
| e) | Date of the transaction | 6 August 2026 | ||||
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.